3/A

OWNERSHIP DOCUMENT

Company: Cellectar Biosciences, Inc.
Filed: April 15, 2022
Period of Report: February 24, 2022
Accession Number: 0001104659-22-046521

View Document ↗ View on SEC.gov ↗